Intuitive Surgical, Inc. $ISRG Shares Sold by DGS Capital Management LLC

DGS Capital Management LLC lowered its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 62.3% during the 1st quarter, Holdings Channel reports. The fund owned 1,201 shares of the medical equipment provider’s stock after selling 1,982 shares during the period. DGS Capital Management LLC’s holdings in Intuitive Surgical were worth $554,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently added to or reduced their stakes in the business. Newbridge Financial Services Group Inc. increased its holdings in shares of Intuitive Surgical by 300.0% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 33 shares during the period. Holos Integrated Wealth LLC acquired a new stake in Intuitive Surgical in the fourth quarter worth about $25,000. Olistico Wealth LLC bought a new position in Intuitive Surgical in the 4th quarter valued at about $28,000. Laurel Wealth Advisors LLC bought a new position in Intuitive Surgical in the 4th quarter valued at about $31,000. Finally, Turning Point Benefit Group Inc. increased its stake in Intuitive Surgical by 833.3% during the 4th quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock valued at $32,000 after buying an additional 50 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. dropped their price target on shares of Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Bank of America decreased their price objective on shares of Intuitive Surgical from $520.00 to $515.00 in a report on Friday, June 12th. Robert W. Baird boosted their target price on Intuitive Surgical from $575.00 to $610.00 and gave the stock an “outperform” rating in a report on Wednesday, April 22nd. Truist Financial cut their target price on Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating for the company in a research report on Wednesday, April 15th. Finally, HSBC decreased their price target on Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Nineteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $571.33.

Insider Buying and Selling

In other Intuitive Surgical news, SVP Iman Jeddi sold 5,625 shares of the company’s stock in a transaction on Monday, June 1st. The stock was sold at an average price of $420.55, for a total value of $2,365,593.75. Following the transaction, the senior vice president owned 6,463 shares of the company’s stock, valued at approximately $2,718,014.65. This represents a 46.53% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the stock in a transaction on Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total value of $169,656.00. Following the sale, the executive vice president owned 5,720 shares of the company’s stock, valued at $2,426,080.80. This trade represents a 6.54% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 7,169 shares of company stock worth $3,059,135. Corporate insiders own 0.60% of the company’s stock.

Intuitive Surgical Trading Up 1.6%

Shares of NASDAQ ISRG opened at $432.83 on Tuesday. Intuitive Surgical, Inc. has a twelve month low of $396.68 and a twelve month high of $603.88. The firm has a 50-day moving average of $427.27 and a two-hundred day moving average of $479.06. The company has a market capitalization of $153.29 billion, a price-to-earnings ratio of 52.46, a PEG ratio of 3.47 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The company had revenue of $2.77 billion for the quarter, compared to analysts’ expectations of $2.62 billion. During the same quarter in the previous year, the company posted $1.81 EPS. The business’s revenue was up 23.0% compared to the same quarter last year. As a group, research analysts predict that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.